Zdrowie i gospodarka · 31/07/2000

FDA Releases Revised Draft Guidance for Medical Imaging Drugs and Biologics

The Food and Drug Administration (FDA) has made available a revised draft guidance for the development of medical imaging drugs and biologics, which aims to assist industry developers in conducting clinical investigations and submitting applications for these products, following comments from industry and other stakeholders.